Infection Control Market by Product & Service (Sterilization, Cleaning & Disinfection Products, Protective Barriers, and Endoscope Reprocessing Products) and End User (Hospitals & Clinics, Pharmaceutical & Medical Device Companies, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2028
- ALL4621692
- 220 Pages
- May 2021
- Medical Devices
Infectious diseases are caused by microorganisms such as viruses, bacteria, parasites, or fungi. Infection can be classified into various types, which include hospital acquired infections (HAIs), ear infections, eye infections, lung & respiratory infections, skin infections, common childhood infections, sexually transmitted infections, and stomach & intestinal infections. These infections can be controlled through a number of products such as sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products. Protective barrier products include surgical gowns, face masks, coveralls, and others.
The growth of the infection control market is driven by rise in number of surgical procedures, increase in incidence of hospital-acquired infections, surge in geriatric population, technological advancements in sterilization equipment, and rise in incidence of chronic diseases across the globe. In addition, rise in outsourcing of sterilization services among hospitals, and pharmaceutical & medical device companies further boosts the growth of the market. Moreover, re-introduction of ethylene oxide sterilization, increase in use of E-beam sterilization, surge in awareness of environmental & personal hygiene due to COVID-19 is another factor that fuels the growth of the market. However, adverse effects of chemical disinfectants and concerns regarding the safety of reprocessed instruments are expected to restrain the growth of the infection control market. Conversely, rise in adoption of single use medical nonwovens and devices is expected to offer lucrative opportunities during the forecast period.
The infection control market is segmented into product & service, end user, and region. On the basis of product & service, the market is categorized into sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products. By sterilization, the market is divided into sterilization product, contract sterilization services, and sterilization consumables & accessories. The sterilization product segment is further classified into heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment, and other sterilization equipment. The contract sterilization services segment is further divided into ethylene oxide sterilization, e-beam sterilization, gamma sterilization, and others. The sterilization consumables & accessories segment is further classified into sterilization indicators and packaging accessories. By cleaning & disinfection products, the market is divided into disinfectants, disinfectors equipment, and others. The disinfectants segment is further divided into wipes, liquids, and sprays. By protective barriers, the market is categorized into medical nonwoven and gloves. The medical nonwoven segment is further divided into surgical gowns, face masks, coveralls, and others. By end user, the market is categorized into hospitals & clinics, pharmaceutical & medical device companies, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2020 to 2028, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of four regions is provided to determine the existing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Product & Service
• Sterilization
o Sterilization Product
Heat Sterilization Equipment
Low Temperature Sterilization Equipment
Radiation Sterilization Equipment
Other Sterilization Equipment
o Contract Sterilization Services
Ethylene Oxide Sterilization
E-beam Sterilization
Gamma Sterilization
Others
o Sterilization Consumables & Accessories
Sterilization Indicators
Packaging Accessories
• Cleaning & Disinfection Products
o Disinfectants
Wipes
Liquids
Sprays
o Disinfectors Equipment
o Others
• Protective Barriers
o Medical Nonwoven
Surgical Gowns
Face Masks
Coveralls
Others
o Gloves
• Endoscope Reprocessing Products
By End User
• Hospitals & Clinics
• Pharmaceutical & Medical Device Companies
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• 3M Company
• Belimed AG
• Ecolab Inc
• Fortive (Advanced Sterilization Products)
• Getinge AB
• Matachana Group
• Miele Group (Steelco SpA)
• MMM Group
• Sotera Health Llc
• Steris Plc (Cantel Medical Corporation)
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
• Danaher Corporation (Metrex Research Llc)
• Reckitt Benckiser
• Pal International
1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Rise in incidence of hospital-acquired infections (HAIs)
3.5.1.2.Upsurge in likelihood of epidemic or pandemic outbreaks
3.5.1.3.Increase in geriatric population and rise in incidence of chronic diseases
3.5.1.4.Rise in use of E-beam sterilization
3.5.2.Restraint
3.5.2.1.Adverse effects of chemical disinfectants
3.5.3.Opportunities
3.5.3.1.Growth opportunities in emerging markets
3.5.4.Impact analysis
3.6.Covid-19 Impact analysis on infection control market
CHAPTER 4:INFECTION CONTROL MARKET, BY PRODUCT & SERVICE
4.1.Overview
4.1.1.Market size and forecast
4.2.Sterilization
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by type
4.2.4.1.Sterilization product
4.2.4.1.1.Market size and forecast
4.2.4.1.2.Market size and forecast, by type
4.2.4.1.2.1.Heat sterilization equipment
4.2.4.1.2.1.1.Market size and forecast
4.2.4.1.2.2.Low temperature sterilization equipment
4.2.4.1.2.2.1.Market size and forecast
4.2.4.1.2.3.Radiation sterilization equipment
4.2.4.1.2.3.1.Market size and forecast
4.2.4.1.2.4.Other sterilization equipment
4.2.4.1.2.4.1.Market size and forecast
4.2.4.2.Contract sterilization services
4.2.4.2.1.Market size and forecast
4.2.4.2.2.Market size and forecast, by type
4.2.4.2.2.1.Ethylene oxide sterilization
4.2.4.2.2.1.1.Market size and forecast
4.2.4.2.2.2.E-beam sterilization
4.2.4.2.2.2.1.Market size and forecast
4.2.4.2.2.3.Gamma sterilization
4.2.4.2.2.3.1.Market size and forecast
4.2.4.2.2.4.Others
4.2.4.2.2.4.1.Market size and forecast
4.2.4.3.Sterilization consumables and accessories
4.2.4.3.1.Market size and forecast
4.2.4.3.2.Market size and forecast, by type
4.2.4.3.2.1.Sterilization indicators
4.2.4.3.2.1.1.Market size and forecast
4.2.4.3.2.2.Packaging accessories
4.2.4.3.2.2.1.Market size and forecast
4.3.Cleaning & Disinfection Products
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by type
4.3.4.1.Disinfectants
4.3.4.1.1.Market size and forecast
4.3.4.1.2.Market size and forecast, by type
4.3.4.1.2.1.Wipes
4.3.4.1.2.1.1.Market size and forecast
4.3.4.1.2.2.Liquids
4.3.4.1.2.2.1.Market size and forecast
4.3.4.1.2.3.Sprays
4.3.4.1.2.3.1.Market size and forecast
4.3.4.2.Disinfectors equipment
4.3.4.2.1.Market size and forecast
4.3.4.3.Others
4.3.4.3.1.Market size and forecast
4.4.Protective Barriers
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.4.4.Market size and forecast, by type
4.4.4.1.Medical Nonwoven
4.4.4.1.1.Market size and forecast
4.4.4.1.2.Market size and forecast, by type
4.4.4.1.2.1.Surgical gowns
4.4.4.1.2.1.1.Market size and forecast
4.4.4.1.2.2.Face masks
4.4.4.1.2.2.1.Market size and forecast
4.4.4.1.2.3.Coveralls
4.4.4.1.2.3.1.Market size and forecast
4.4.4.1.2.4.Others
4.4.4.1.2.4.1.Market size and forecast
4.4.4.2.Gloves
4.4.4.2.1.Market size and forecast
4.5.Endoscope reprocessing products
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
CHAPTER 5:INFECTION CONTROL MARKET, BY END USER
5.1.Overview
5.1.1.Market size and forecast
5.2.Hospitals & clinics
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Pharmaceutical & medical device companies
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Others
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
CHAPTER 6:INFECTION CONTROL MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by country
6.2.2.1.U.S.
6.2.2.1.1.U.S. infection control market, by product & service
6.2.2.1.2.U.S. infection control market, by end user
6.2.2.2.Canada
6.2.2.2.1.Canada infection control market, by product & service
6.2.2.2.2.Canada infection control market, by end user
6.2.2.3.Mexico
6.2.2.3.1.Mexico infection control market, by product & service
6.2.2.3.2.Mexico infection control market, by end user
6.2.3.North America market size and forecast, by product & service
6.2.4.North America market size and forecast, by end user
6.3.Europe
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by country
6.3.2.1.Germany
6.3.2.1.1.Germany infection control market, by product & service
6.3.2.1.2.Germany infection control market, by end user
6.3.2.2.France
6.3.2.2.1.France infection control market, by product & service
6.3.2.2.2.France infection control market, by end user
6.3.2.3.UK
6.3.2.3.1.UK infection control market, by product & service
6.3.2.3.2.UK infection control market, by end user
6.3.2.4.Italy
6.3.2.4.1.Italy infection control market, by product & service
6.3.2.4.2.Italy infection control market, by end user
6.3.2.5.Spain
6.3.2.5.1.Spain infection control market, by product & service
6.3.2.5.2.Spain infection control market, by end user
6.3.2.6.Rest of Europe
6.3.2.6.1.Rest of Europe infection control market, by product & service
6.3.2.6.2.Rest of Europe infection control market, by end user
6.3.3.Europe market size and forecast, by product & service
6.3.4.Europe market size and forecast, by end user
6.4.Asia-Pacific
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by country
6.4.2.1.Japan
6.4.2.1.1.Japan infection control market, by product & service
6.4.2.1.2.Japan infection control market, by end user
6.4.2.2.China
6.4.2.2.1.China infection control market, by product & service
6.4.2.2.2.China infection control market, by end user
6.4.2.3.Australia
6.4.2.3.1.Australia infection control market, by product & service
6.4.2.3.2.Australia infection control market, by end user
6.4.2.4.India
6.4.2.4.1.India infection control market, by product & service
6.4.2.4.2.India infection control market, by end user
6.4.2.5.South Korea
6.4.2.5.1.South Korea infection control market, by product & service
6.4.2.5.2.South Korea infection control market, by end user
6.4.2.6.Rest of Asia-Pacific
6.4.2.6.1.Rest of Asia-Pacific infection control market, by product & service
6.4.2.6.2.Rest of Asia-Pacific infection control market, by end user
6.4.3.Asia-Pacific market size and forecast, by product & service
6.4.4.Asia-Pacific market size and forecast, by end user
6.5.LAMEA
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by country
6.5.2.1.Brazil
6.5.2.1.1.Brazil infection control market, by product & service
6.5.2.1.2.Brazil infection control market, by end user
6.5.2.2.Saudi Arabia
6.5.2.2.1.Saudi Arabia infection control market, by product & service
6.5.2.2.2.Saudi Arabia infection control market, by end user
6.5.2.3.South Africa
6.5.2.3.1.South Africa infection control market, by product & service
6.5.2.3.2.South Africa infection control market, by end user
6.5.2.4.Rest of LAMEA
6.5.2.4.1.Rest of LAMEA infection control market, by product & service
6.5.2.4.2.Rest of LAMEA infection control market, by end user
6.5.3.LAMEA market size and forecast, by product & service
6.5.4.LAMEA market size and forecast, by end user
CHAPTER 7:COMPANY PROFILES
7.1.3M COMPANY
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments
7.2.BELIMED AG.
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.3.ECOLAB INC.
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.FORTIVE CORPORATION (ADVANCED STERILIZATION PRODUCTS).
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments
7.5.GENITGE AB.
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments
7.6.MATACHANA GROUP.
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Key strategic moves and developments
7.7.MIELE GROUP. (STEELCO)
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.8.MMM GROUP
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.9.SOTERA HEALTH INC.
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments
7.10.STERIS PLC (CANTEL MEDICAL CORPORATION).
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
7.10.6.Key strategic moves and developments
TABLE 01.INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 02.INFECTION CONTROL MARKET FOR STERILIZATION, BY REGION, 2020-2028 ($MILLION)
TABLE 03.STERILIZATION INFECTION CONTROL MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 04.STERILIZATION PRODUCT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 05.CONTRACT STERILIZATION SERVICES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 06.STERILIZATION CONSUMABLES AND ACCESSORIES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 07.INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY REGION, 2020-2028 ($MILLION)
TABLE 08.CLEANING & DISINFECTION PRODUCTS INFECTION CONTROL MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 09.DISINFECTANTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 10.INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY REGION, 2020-2028 ($MILLION)
TABLE 11.INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2020–2028 ($MILLION)
TABLE 12.MEDICAL NONWOVEN MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 13.INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY REGION, 2020-2028 ($MILLION)
TABLE 14.INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 15.INFECTION CONTROL MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2028 ($MILLION)
TABLE 16.INFECTION CONTROL MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE COMPANIES, BY REGION, 2020-2028 ($MILLION)
TABLE 17.INFECTION CONTROL MARKET FOR OTHERS, BY REGION, 2020-2028 ($MILLION)
TABLE 18.INFECTION CONTROL MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 19.NORTH AMERICA INFECTION CONTROL MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 20.U.S. INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 21.U.S. INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 22.CANADA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 23.CANADA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 24.MEXICO INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 25.MEXICO INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 26.NORTH AMERICA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 27.NORTH AMERICA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 28.EUROPE INFECTION CONTROL MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 29.GERMANY INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 30.GERMANY INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 31.FRANCE INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 32.FRANCE INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 33.UK INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 34.UK INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 35.ITALY INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 36.ITALY INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 37.SPAIN INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 38.SPAIN INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 39.REST OF EUROPE INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 40.REST OF EUROPE INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 41.EUROPE INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 42.EUROPE INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 43.ASIA-PACIFIC INFECTION CONTROL MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 44.JAPAN INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 45.JAPAN INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 46.CHINA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 47.CHINA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 48.AUSTRALIA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 49.AUSTRALIA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 50.INDIA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 51.INDIA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 52.SOUTH KOREA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 53.SOUTH KOREA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 54.REST OF ASIA-PACIFIC INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 55.REST OF ASIA-PACIFIC INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 56.ASIA-PACIFIC INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 57.ASIA-PACIFIC INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 58.LAMEA INFECTION CONTROL MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 59.BRAZIL INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 60.BRAZIL INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 61.SAUDI ARABIA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 62.SAUDI ARABIA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 63.SOUTH AFRICA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 64.SOUTH AFRICA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 65.REST OF LAMEA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 66.REST OF LAMEA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 67.LAMEA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 68.LAMEA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 69.3M: COMPANY SNAPSHOT
TABLE 70.3M: OPERATING SEGMENTS
TABLE 71.3M: PRODUCT PORTFOLIO
TABLE 72.BELIMED: COMPANY SNAPSHOT
TABLE 73.BELIMED: OPERATING SEGMENTS
TABLE 74.BELIMED: PRODUCT PORTFOLIO
TABLE 75.ECOLAB: COMPANY SNAPSHOT
TABLE 76.ECOLAB: OPERATING SEGMENTS
TABLE 77.ECOLAB: PRODUCT PORTFOLIO
TABLE 78.FORTIVE: COMPANY SNAPSHOT
TABLE 79.FORTIVE: OPERATING SEGMENTS
TABLE 80.FORTIVE: PRODUCT PORTFOLIO
TABLE 81.GENITGE: COMPANY SNAPSHOT
TABLE 82.GETINGE: OPERATING SEGMENTS
TABLE 83.GETINGE: PRODUCT PORTFOLIO
TABLE 84.MATACHNA: COMPANY SNAPSHOT
TABLE 85.MATACHANA: OPERATING SEGMENTS
TABLE 86.MATACHANA: PRODUCT PORTFOLIO
TABLE 87.MIELE: COMPANY SNAPSHOT
TABLE 88.MIELE: OPERATING SEGMENTS
TABLE 89.MIELE: PRODUCT PORTFOLIO
TABLE 90.MMM COMPANY SNAPSHOT
TABLE 91.MMM: OPERATING SEGMENTS
TABLE 92.MMM: PRODUCT PORTFOLIO
TABLE 93.SOTERA HEALTH: COMPANY SNAPSHOT
TABLE 94.SOTERA HEALTH: OPERATING SEGMENTS
TABLE 95.SOTERA HEALTH: PRODUCT PORTFOLIO
TABLE 96.STERIS: COMPANY SNAPSHOT
TABLE 97.STERIS: OPERATING SEGMENTS
TABLE 98.STERIS: PRODUCT PORTFOLIO
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
